Brief: Elos Medtech Resolves On Rights Issue Worth SEK 4.34 Bln

Elos Medtech AB

14/08/2023 07:12

Aug 14 (Reuters) - Elos Medtech AB  ELOSSb.ST :
    * SAID ON SATURDAY, BOD DECIDES TO CARRY OUT NEW ISSUE OF
SHARES
OF CLASS B OF UP TO ABOUT SEK 4,337 MILLION
    * SUBSCRIPTION PRICE IN RIGHTS ISSUE IS SEK 215 PER NEW
SHARE OF
CLASS B
    * PURPOSE OF RIGHTS ISSUE IS TO FINANCE ACQUISITION OF
KLINGEL
HOLDING GMBH
    * TOTAL ISSUE PROCEEDS OF UP TO ABOUT SEK 4,337 MILLION
BEFORE
DEDUCTION OF TRANSACTION COSTS OF ABOUT SEK 8.2 MILLION
    * RIGHTS ISSUE IS FULLY GUARANTEED THROUGH SUBSCRIPTION,
GUARANTEE
UNDERTAKING FROM CO'S PRINCIPAL SHAREHOLDER, TA ASSOCIATES,
THROUGH EM INTRESSENTER AB
    * ISSUE SUBJECT TO APPROVAL BY EGM

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr9NW07W
 Further company coverage:  ELOSSb.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))